Skip to Content

← See all Ranitidine 150 brands

Ranitidine 150 by Allegiant Health

Dosage form: tablet, coated
Ingredients: RANITIDINE HYDROCHLORIDE 150mg
Labeler: Allegiant Health
NDC Code: 69168-375

375 - Health A2Z Acid Reducer 150mg

Active ingredient (in each tablet)

Ranitidine 150mg (as ranitidine hydrochloride, USP 168mg)

Purpose

 Acid reducer

Uses
  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages

Warnings

Allergy alert:

Do not use if you are allergic to ranitidine or other acid reducers

Do not use
  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor.

Ask a doctor before use if you have
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain
  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness

Stop use and ask a doctor if
  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

adults and children 12 years of age and over:

  • to relieve symptoms, swallow 1 tablet with a glass of water
  • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
  • can be used up to twice daily (do not take more than 2 tablets in 24 hours)

children under 12 years: ask a doctor

Other information
  • do not use if the individual blister unit is open or torn
  • store at 20ºC to 25ºC (68ºF to 77ºF)
  • avoid excessive heat or humidity
  • protect from light
  • this product is sugar free

Inactive ingredients

carnauba wax, hypromellose, magnesium stearate, microcrystalline cellulose, polydextrose, red and yellow 

ferric oxide, silicon dioxide, titanium dioxide, vanillin

Questions or comments?

1-888-952-0050 Monday through Friday 9AM-5PM EST

Principal Display Panel

 Health A2Z®

*Compare to Zantac 150® Active Ingredient

ACID REDUCER 150

MAXIMUM STRENGTH

Ranitidine 150 mg

(as ranitidine hydrochloride, USP 168 mg)

RELIEVES & PREVENTS HEARTBURN associated with acid indigestion and sour stomach

(pill image)

8 Tablets

Ranitidine 150mg 8ct. Tablets

RANITIDINE 150 
ranitidine hydrochloride tablets 150mg tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69168-375
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RANITIDINE HYDROCHLORIDE (RANITIDINE) RANITIDINE150 mg
Inactive Ingredients
Ingredient NameStrength
FD&C RED NO. 40 
HYPROMELLOSE 2910 (6 MPA.S) 
FERROSOFERRIC OXIDE 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
POLYETHYLENE GLYCOL 400 
TITANIUM DIOXIDE 
VANILLIN 
Product Characteristics
ColorPINKScoreno score
ShapeROUNDSize9mm
FlavorImprint CodeAPO;150
Contains    
Packaging
#Item CodePackage Description
1NDC:69168-375-291 BLISTER PACK in 1 CARTON
18 TABLET, COATED in 1 BLISTER PACK
2NDC:69168-375-932 BLISTER PACK in 1 CARTON
212 TABLET, COATED in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07819201/05/2010
Labeler - Allegiant Health (079501930)
Establishment
NameAddressID/FEIOperations
Apotex Inc.205576023ANALYSIS(69168-375), MANUFACTURE(69168-375)

 
Allegiant Health

← See all Ranitidine 150 brands

Medically reviewed on Nov 12, 2017

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide